Urokinase use was lower for Palindrome than for HemoStar , as evidenced by a lower number of urokinase infusions/@ ,@ catheter-days ( @ and @ ; P < @ ) and higher number of catheters that never required thrombolysis ( @ % and @ % ; P = @ ) .